For the first time scientists have identified promising drug candidates that bind irreversibly with a notoriously "undruggable" cancer protein target, permanently blocking it.

Gene expression testing helps determine chemotherapy needs for hormone receptor-positive breast cancer, optimizing treatment ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

The following is a summary of “Disruption of the sorcin‒PAX5 protein‒protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquitination of ALDH1A1 in pancreatic cancer,” published ...

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide, with approximately 20% of patients ...

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...

Dr. Regina Hampton highlighted unmet needs in black women with breast cancer and details how genomic information can drive ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

Scientists suggest understanding ecDNA’s role in pancreatic cancer could potentially guide future strategies for making ...

Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...